Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Xilio Therapeutics (XLO)
NASDAQ:XLO
Xilio Therapeutics (XLO) Stock Price & Analysis
98 Followers
XLO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.49 - $3.25
Previous Close$1.09
Volume117.58K
Average Volume (3M)1.26M
Market Cap
$40.23M
Enterprise Value-$5.18M
Total Cash (Recent Filing)$59.80M
Total Debt (Recent Filing)$14.39M
Price to Earnings (P/E)-0.4
Beta1.16
Next Earnings
Aug 06, 2024EPS Estimate
-$0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.57
Shares Outstanding34,473,486
10 Day Avg. Volume207,182
30 Day Avg. Volume1,261,815
Standard Deviation0.24
R-Squared0.00037
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)0.74
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.07
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Xilio Therapeutics News
Ownership Overview
70.70% Insiders
3.14% Mutual Funds
21.23% Other Institutional Investors
4.93% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
XLO FAQ
What was Xilio Therapeutics’s price range in the past 12 months?
Xilio Therapeutics lowest stock price was $0.49 and its highest was $3.25 in the past 12 months.
What is Xilio Therapeutics’s market cap?
Currently, no data Available
When is Xilio Therapeutics’s upcoming earnings report date?
Xilio Therapeutics’s upcoming earnings report date is Aug 06, 2024 which is in 82 days.
How were Xilio Therapeutics’s earnings last quarter?
Xilio Therapeutics released its earnings results on May 14, 2024. The company reported -$0.62 earnings per share for the quarter, missing the consensus estimate of -$0.11 by -$0.51.
Is Xilio Therapeutics overvalued?
According to Wall Street analysts Xilio Therapeutics’s price is currently Overvalued.
Does Xilio Therapeutics pay dividends?
Xilio Therapeutics does not currently pay dividends.
What is Xilio Therapeutics’s EPS estimate?
Xilio Therapeutics’s EPS estimate is -$0.23.
How many shares outstanding does Xilio Therapeutics have?
Xilio Therapeutics has 36,912,216 shares outstanding.
What happened to Xilio Therapeutics’s price movement after its last earnings report?
Xilio Therapeutics reported an EPS of -$0.62 in its last earnings report, missing expectations of -$0.11. Following the earnings report the stock price went down -2.679%.
Which hedge fund is a major shareholder of Xilio Therapeutics?
Among the largest hedge funds holding Xilio Therapeutics’s share is Deerfield Management Company, LP. It holds Xilio Therapeutics’s shares valued at N/A.
---
Xilio Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 3.7M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $368.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.1%
Last 30 Days ▲ 8.1%
Last 30 Days ▲ 8.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-65.61%
12-Months-Change
Fundamentals
Return on Equity
-128.37%
Trailing 12-Months
Asset Growth
-25.91%
Trailing 12-Months
Company Description
Xilio Therapeutics
Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer.
---
XLO Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering XLO
1 Year
1 Year Success Rate
2/7 ratings generated profit
1 Year Average Return
-40.93%
reiterated a buy rating 5 months ago
Copying Michael Schmidt's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -40.93% per trade.
---